1) proliferative vitreoretinopathy
增生性玻璃体视网膜病
1.
Objective To observe the expression of nuclear transcription factor-κB protein and proinflammatory factors messenger RNA(mRNA) in periretinal membrane (PRM)of proliferative vitreoretinopathy(PVR).
目的 观察炎前因子mRNA和核因子κB(nucleartranscriptionfactor κB ,NF κB)在增生性玻璃体视网膜病变 (PVR)增生膜中的表达情况。
3) traumatic proliferative vitreoretinopathy
外伤性增生性玻璃体视网膜病变
1.
Research on the intervention of TIMPs-GM6001 in the traumatic proliferative vitreoretinopathy;
基质金属蛋白酶抑制剂GM6001干预外伤性增生性玻璃体视网膜病变的研究
2.
Study on pathomorphology of traumatic proliferative vitreoretinopathy after GM 6001 intervention
GM 6001干预外伤性增生性玻璃体视网膜病变的病理形态学研究
3.
Objective To study the curative and preventive effects of SanXueMingMu tablet on traumatic proliferative vitreoretinopathy(tPVR)in rabbits.
目的探讨活血利水之散血明目片对外伤性增生性玻璃体视网膜病变(traumaticproliferativevitreoretinopathy,tPVR)玻璃体中碱性成纤维细胞生长因子(basicfibroblastsgrowthfactors,bFGF)、表皮生长因子(epidermalgrowthfactor,EGF)和细胞间粘附分子1(intercellularadhesionmolecule1,ICAM1)浓度的影响及防治PVR的作用机理。
4) proliferative vitreoretinopathy
增生性玻璃体视网膜病变
1.
Platelet-derived growth factor and proliferative vitreoretinopathy;
血小板源性生长因子与增生性玻璃体视网膜病变
2.
Antiproliferative effect of CyA-loaded chitosan nanoparticles on experimental proliferative vitreoretinopathy;
环孢素A壳聚糖纳米微粒防治增生性玻璃体视网膜病变
3.
Prevention of PDGF antibody and VEGF antibody on experimental proliferative vitreoretinopathy;
PDGF抗体和VEGF抗体预防增生性玻璃体视网膜病变
5) anterior proliferative vitreoretinopathy
前部增生性玻璃体视网膜病变
1.
A retrospective investigation of anterior proliferative vitreoretinopathy.;
前部增生性玻璃体视网膜病变发病特点和手术
2.
The goal of this paper was to investigate the changes of Cx43 expression in ciliary epithelium during injury and repairing process in anterior proliferative vitreoretinopathy(PVR) and to discuss its mechanism and significance.
目的研究Cx43在前部增生性玻璃体视网膜病变(PVR)睫状体上皮损伤修复过程中表达的变化并探讨其机制和意义。
3.
Objective To study the dynamics of aqueous humor in chronic hypotony induced by traumatic anterior proliferative vitreoretinopathy (aPVR), and to demonstrate physiologic mechanisms of the hypotony.
目的 探讨外伤性前部增生性玻璃体视网膜病变 (aPVR)低眼压状态下的房水生成率、流出率变化 ,从房水动力学的角度揭示外伤性aPVR引起慢性低眼压的发病机制。
6) PVR
增生性玻璃体视网膜病变
1.
The clinical analysis of vitrectomy treating proliferative vitreoretinopathy(PVR).;
玻璃体切除术治疗增生性玻璃体视网膜病变的临床分析
2.
ObjectiveA lot of clinical observations show a close relationship between retinal detachment(RD) and proliferative vitreoretinopathy(PVR).
目的观察大鼠视网膜脱离及复位状态下视网膜色素上皮(RPE)细胞黏附分子的表达变化,探讨其与增生性玻璃体视网膜病变(PVR)发生的关系。
3.
The cause of failure was PVR developing,especially PVR in the anterior part inducing new breaks formed or initial breaks open again [62.
14%,复发原因有:增生性玻璃体视网膜病变(PVR),特别是前段PVR的发展牵引致新孔形成或原孔开放占62。
补充资料：淋巴结病和窦性组织细胞增生症
淋巴结病和窦性组织细胞增生症
〖HT5”SS〗lymplh ?adenopathy and sinus histiocytosis
属Ⅱ类组织细胞增生症。其特点是发热、白细胞增多、颈淋巴结肿大。病理改变为淋巴结包膜下及髓窦组织细胞增生，光镜下很似朗格汉斯细胞组织细胞增生症，但电镜下不见Birbeck颗粒，CDIa阴性。病变不侵犯骨骼、肝、脾、肺、皮肤等组织，仅限于淋巴结。可有暂时性免疫功能低下。非恶性肿瘤。预后较好。对有严重淋巴结破坏者，化疗效果较好。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条